Menin represses tumorigenesis via repressing cell proliferation.

Ting Wu, Xianxin Hua
Author Information

Abstract

Multiple endocrine neoplasia type 1 (MEN1) results from mutations in the tumor suppressor gene, MEN1, which encodes nuclear protein menin. Menin is important for suppressing tumorigenesis in various endocrine and certain non-endocrine tissues. Although menin suppresses MEN1 through a variety of mechanisms including regulating apoptosis and DNA repair, the role of menin in regulating cell proliferation is one of the best-studied functions. Here, we focus on reviewing various mechanisms underlying menin-mediated inhibition of cell proliferation. Menin inhibits cell proliferation to repress MEN1 through multiple mechanisms. 1) Menin interacts with various histonemodifying enzymes, such as MLL, EZH2 and HDACs, to affect gene transcription, leading to repression of cell proliferation. 2) Menin also interacts with various transcription factors, such as JunD, NF-κB, PPARγ and VDR, to induce or suppress gene transcription. As these various transcription factors are known to regulate cell proliferation, their interaction with menin may be relevant to menin's role in inhibiting cell proliferation. 3) Menin inhibits cell proliferation via TGF-β signaling and Wnt/β-catenin signaling pathways. 4) Menin represses certain pro-proliferative factors involved in endocrine tumors such as IGFBP-2, IGF2 and PTHrP to repress cell proliferation. 5) Menin affects cell cycle progression to inhibit cell proliferation. This review is helpful in our understanding of the comprehensive mechanisms whereby menin represses MEN1 through inhibiting cell proliferation.

Keywords

References

  1. Int J Cancer. 2000 Mar 15;85(6):877-81 [PMID: 10709111]
  2. J Biol Chem. 2010 Jun 11;285(24):18291-300 [PMID: 20404349]
  3. Cancer Res. 2004 Mar 15;64(6):2222-8 [PMID: 15026366]
  4. Trends Biochem Sci. 2000 Feb;25(2):64-70 [PMID: 10664585]
  5. Cancer Res. 2001 Dec 15;61(24):8601-10 [PMID: 11751371]
  6. Mol Cell Endocrinol. 2008 Sep 10;291(1-2):109-15 [PMID: 18590796]
  7. Science. 1997 Apr 18;276(5311):404-7 [PMID: 9103196]
  8. Genesis. 2002 Feb;32(2):150-1 [PMID: 11857805]
  9. Cancer Cell. 2008 Jul 8;14(1):36-46 [PMID: 18598942]
  10. Cancer Res. 2003 Sep 1;63(17):5420-7 [PMID: 14500377]
  11. Oncogene. 2009 Nov 19;28(46):4095-104 [PMID: 19749796]
  12. Lab Invest. 1999 Mar;79(3):301-10 [PMID: 10092066]
  13. Oncogene. 1999 Oct 21;18(43):5936-42 [PMID: 10557080]
  14. Development. 2007 Jan;134(2):223-32 [PMID: 17185323]
  15. Oncogene. 2009 Feb 19;28(7):973-82 [PMID: 19079338]
  16. Science. 2007 Nov 2;318(5851):806-9 [PMID: 17975067]
  17. Mech Dev. 2003 May;120(5):549-60 [PMID: 12782272]
  18. Endocrinology. 2004 Jul;145(7):3443-50 [PMID: 15044367]
  19. Science. 2002 Nov 1;298(5595):1039-43 [PMID: 12351676]
  20. J Biol Chem. 2002 Apr 19;277(16):14153-8 [PMID: 11809760]
  21. Clin Endocrinol (Oxf). 2004 Mar;60(3):389-93 [PMID: 15009006]
  22. Int J Cancer. 2009 Mar 1;124(5):1122-32 [PMID: 19058182]
  23. Trends Endocrinol Metab. 2006 Nov;17(9):357-64 [PMID: 16997566]
  24. Biochem Biophys Res Commun. 2001 Aug 17;286(2):426-31 [PMID: 11500056]
  25. Mol Cell. 2004 Feb 27;13(4):587-97 [PMID: 14992727]
  26. Cancer Res. 2003 Jul 15;63(14):4204-10 [PMID: 12874027]
  27. J Biol Chem. 2001 May 18;276(20):16772-9 [PMID: 11278720]
  28. Mol Cancer Res. 2008 Dec;6(12):1894-907 [PMID: 19074834]
  29. Cancer Sci. 2009 Feb;100(2):209-15 [PMID: 19068082]
  30. J Oral Pathol Med. 2006 Sep;35(8):472-8 [PMID: 16918598]
  31. J Biol Chem. 2004 Mar 12;279(11):10685-91 [PMID: 14688275]
  32. Mol Cell Biol. 2004 Jul;24(13):5639-49 [PMID: 15199122]
  33. Hum Mutat. 2008 Jan;29(1):22-32 [PMID: 17879353]
  34. Cancer Res. 2003 Oct 1;63(19):6135-9 [PMID: 14559791]
  35. Endocr Rev. 1998 Dec;19(6):798-827 [PMID: 9861546]
  36. Biochim Biophys Acta. 1999 Oct 6;1447(1):51-6 [PMID: 10500243]
  37. Mol Endocrinol. 2003 Sep;17(9):1880-92 [PMID: 12819299]
  38. Mol Cell Biol. 2009 Sep;29(18):5060-9 [PMID: 19596783]
  39. Endocrinology. 1990 Jul;127(1):126-32 [PMID: 2163307]
  40. Oncogene. 1998 Nov 12;17(19):2485-93 [PMID: 9824159]
  41. Cancer Res. 2004 Sep 15;64(18):6791-6 [PMID: 15374998]
  42. Cancer Res. 2006 May 1;66(9):4929-35 [PMID: 16651450]
  43. Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):3837-42 [PMID: 11274402]
  44. Mol Cell Biol. 2003 Oct;23(20):7222-9 [PMID: 14517292]
  45. Nat Med. 1995 Dec;1(12):1309-11 [PMID: 7489414]
  46. Nat Rev Cancer. 2006 Nov;6(11):846-56 [PMID: 17060944]
  47. Endocr Relat Cancer. 2005 Dec;12(4):929-37 [PMID: 16322332]
  48. Mol Cell Endocrinol. 2009 Dec 10;313(1-2):1-8 [PMID: 19729047]
  49. J Biol Chem. 2005 Jul 22;280(29):26953-64 [PMID: 15908427]
  50. J Clin Endocrinol Metab. 2000 May;85(5):2000-3 [PMID: 10843188]
  51. J Biol Chem. 2004 Sep 24;279(39):40267-75 [PMID: 15150273]
  52. Cancer Res. 2007 Aug 1;67(15):7275-83 [PMID: 17671196]
  53. Genes Dev. 1998 Sep 15;12(18):2899-911 [PMID: 9744866]
  54. Endocr Rev. 2008 Oct;29(6):726-76 [PMID: 18694980]
  55. Cell. 2007 Feb 23;128(4):735-45 [PMID: 17320510]
  56. Adv Intern Med. 1997;42:597-627 [PMID: 9048131]
  57. Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):1018-23 [PMID: 16415155]
  58. Genes Chromosomes Cancer. 2002 Sep;35(1):81-5 [PMID: 12203793]
  59. Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1118-23 [PMID: 11158604]
  60. Cancer Res. 2001 Feb 1;61(3):916-20 [PMID: 11221882]
  61. Exp Cell Res. 2002 Aug 15;278(2):175-83 [PMID: 12169273]
  62. Lab Invest. 2000 Jun;80(6):797-804 [PMID: 10879731]
  63. J Biol Chem. 2007 Oct 26;282(43):31332-40 [PMID: 17766243]
  64. Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1630-4 [PMID: 9465067]
  65. QJM. 1996 Sep;89(9):653-69 [PMID: 8917740]
  66. Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):749-54 [PMID: 15640349]
  67. Cancer Res. 1999 Oct 15;59(20):5097-101 [PMID: 10537281]
  68. Eur J Endocrinol. 2006 Jan;154(1):159-66 [PMID: 16382005]
  69. Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13462-7 [PMID: 10557343]
  70. Oncogene. 2001 Aug 16;20(36):4917-25 [PMID: 11526476]
  71. Clin Endocrinol (Oxf). 2000 Sep;53(3):373-81 [PMID: 10971456]
  72. Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10770-5 [PMID: 12960363]
  73. Mol Cell Endocrinol. 2007 Feb;265-266:34-41 [PMID: 17222504]
  74. Cancer Res. 2006 Jun 1;66(11):5707-15 [PMID: 16740708]
  75. Curr Opin Cell Biol. 1997 Apr;9(2):240-6 [PMID: 9069263]
  76. Int J Cancer. 2003 May 20;105(1):14-9 [PMID: 12672024]
  77. Mol Cell Biol. 2003 Jan;23(2):493-509 [PMID: 12509449]
  78. Br J Cancer. 2002 Mar 18;86(6):858-63 [PMID: 11953815]
  79. Oncogene. 2006 Jun 15;25(25):3537-46 [PMID: 16449969]
  80. Nucleic Acids Res. 2006 Jan 24;34(2):543-54 [PMID: 16434701]
  81. Proc Natl Acad Sci U S A. 2010 Nov 23;107(47):20358-63 [PMID: 21059956]
  82. J Biol Chem. 1999 Jun 11;274(24):17088-97 [PMID: 10358062]
  83. Cell. 2005 Oct 21;123(2):207-18 [PMID: 16239140]
  84. Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14659-64 [PMID: 16195383]
  85. Mol Cell Endocrinol. 1999 Oct 25;156(1-2):25-33 [PMID: 10612420]
  86. J Cell Biochem. 2006 Aug 15;98(6):1450-6 [PMID: 16518840]
  87. Cell Cycle. 2007 Dec 1;6(23):2877-83 [PMID: 18156802]
  88. Mol Cell Biol. 2009 Oct;29(20):5477-87 [PMID: 19651895]
  89. Development. 2006 May;133(10):2023-32 [PMID: 16611688]
  90. Endocr Relat Cancer. 2008 Mar;15(1):217-27 [PMID: 18310289]
  91. Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2603-8 [PMID: 10706604]
  92. J Cell Physiol. 2002 Jan;190(1):63-73 [PMID: 11807812]
  93. Endocr Relat Cancer. 2006 Dec;13(4):1223-36 [PMID: 17158767]
  94. Annu Rev Biochem. 1998;67:753-91 [PMID: 9759503]
  95. Endocr Relat Cancer. 2008 Mar;15(1):267-75 [PMID: 18310293]
  96. Cancer Res. 2003 Nov 15;63(22):8022-8 [PMID: 14633735]
  97. Cancer Res. 2000 Feb 15;60(4):834-8 [PMID: 10706089]
  98. J Clin Invest. 2010 Feb;120(2):593-606 [PMID: 20093773]
  99. Cell. 1999 Jan 8;96(1):143-52 [PMID: 9989505]
  100. Cell. 2000 Oct 13;103(2):295-309 [PMID: 11057902]
  101. J Clin Invest. 2003 May;111(9):1381-8 [PMID: 12727930]
  102. J Clin Invest. 2001 May;107(9):1093-102 [PMID: 11342573]
  103. J Clin Endocrinol Metab. 2001 Dec;86(12):5658-71 [PMID: 11739416]

Grants

  1. R01 CA113962/NCI NIH HHS

Word Cloud

Created with Highcharts 10.0.0cellproliferationMeninMEN1meninvarioustranscriptiongenemechanismsendocrinefactorsrepresses1tumorigenesiscertainregulatingroleinhibitsrepressinteractsinhibitingviasignalingcycleMultipleneoplasiatyperesultsmutationstumorsuppressorencodesnuclearproteinimportantsuppressingnon-endocrinetissuesAlthoughsuppressesvarietyincludingapoptosisDNArepaironebest-studiedfunctionsfocusreviewingunderlyingmenin-mediatedinhibitionmultiplehistonemodifyingenzymesMLLEZH2HDACsaffectleadingrepression2alsoJunDNF-κBPPARγVDRinducesuppressknownregulateinteractionmayrelevantmenin's3TGF-βWnt/β-cateninpathways4pro-proliferativeinvolvedtumorsIGFBP-2IGF2PTHrP5affectsprogressioninhibitreviewhelpfulunderstandingcomprehensivewherebyrepressingepigenetics

Similar Articles

Cited By